IDEAYA Biosciences (IDYA) Amortizatization of Intangibles (2018 - 2026)
IDEAYA Biosciences' (IDYA) quarterly Amortizatization of Intangibles came in at $455000.0 in Q1 2026, down 14.63% year-on-year from $533000.0 in Q1 2025, and down 70.14% quarter-over-quarter from $1.5 million in Q4 2025.
IDEAYA Biosciences (IDYA) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
IDEAYA Biosciences has disclosed Amortizatization of Intangibles across 9 years of filings, most recently posting $455000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $455000.0, down 14.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.9 million (up 553.76% YoY), and the FY2025 annual result was $10.0 million, up 589.43% from the prior year.
- Amortizatization of Intangibles came in at $455000.0 for Q1 2026 at IDEAYA Biosciences, down from $1.5 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $17.4 million in Q3 2024 to a low of -$16.9 million in Q4 2024.
- The 5-year median for Amortizatization of Intangibles is $533000.0 (2025), against an average of $1.5 million.
- Across the five-year window, Amortizatization of Intangibles soared 715.1% in 2023 and slumped 535.24% in 2024, its largest moves.
- IDEAYA Biosciences' Amortizatization of Intangibles stood at $1.8 million in 2022, then jumped by 109.97% to $3.9 million in 2023, then plunged by 535.24% to -$16.9 million in 2024, then surged by 109.03% to $1.5 million in 2025, then plunged by 70.14% to $455000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $455000.0 (Q1 2026), $1.5 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | IDEAYA Biosciences | 2.78 Bn | 2.10 Bn | - | 455,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 455,000.00 |
| Mar 31, 2026 | 455,000.00 |
| Dec 31, 2025 | 1.52 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 7.40 Mn |
| Sep 30, 2025 | 7.40 Mn |
| Jun 30, 2025 | 515,000.00 |
| Jun 30, 2025 | 515,000.00 |
| Mar 31, 2025 | 533,000.00 |
| Mar 31, 2025 | 533,000.00 |
| Dec 31, 2024 | -16.87 Mn |
| Dec 31, 2024 | -16.87 Mn |
| Sep 30, 2024 | 17.38 Mn |
| Sep 30, 2024 | 17.38 Mn |
| Jun 30, 2024 | 475,000.00 |
| Jun 30, 2024 | 475,000.00 |
| Mar 31, 2024 | 466,000.00 |
| Mar 31, 2024 | 466,000.00 |
| Dec 31, 2023 | 3.88 Mn |
| Dec 31, 2023 | 3.88 Mn |